000			01978 a2200529 4500
005			20250518095456.0
264		0	_c20210106
008			202101s 0 0 eng d
022			_a1569-8041
024	7		_a10.1016/j.annonc.2020.04.001 _2doi
040			_aNLM _beng _cNLM
100	1		_aFerris, R L
245	0	0	_aDurvalumab with or without tremelimumab in patients with recurrent or metastatic head and neck squamous cell carcinoma: EAGLE, a randomized, open-label phase III study. _h[electronic resource]
260			_bAnnals of oncology : official journal of the European Society for Medical Oncology _c07 2020
300			_a942-950 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAntibodies, Monoclonal
650	0	4	_aAntibodies, Monoclonal, Humanized _xtherapeutic use
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aHead and Neck Neoplasms _xdrug therapy
650	0	4	_aHumans
650	0	4	_aNeoplasm Recurrence, Local _xdrug therapy
650	0	4	_aSquamous Cell Carcinoma of Head and Neck _xdrug therapy
700	1		_aHaddad, R
700	1		_aEven, C
700	1		_aTahara, M
700	1		_aDvorkin, M
700	1		_aCiuleanu, T E
700	1		_aClement, P M
700	1		_aMesia, R
700	1		_aKutukova, S
700	1		_aZholudeva, L
700	1		_aDaste, A
700	1		_aCaballero-Daroqui, J
700	1		_aKeam, B
700	1		_aVynnychenko, I
700	1		_aLafond, C
700	1		_aShetty, J
700	1		_aMann, H
700	1		_aFan, J
700	1		_aWildsmith, S
700	1		_aMorsli, N
700	1		_aFayette, J
700	1		_aLicitra, L
773	0		_tAnnals of oncology : official journal of the European Society for Medical Oncology _gvol. 31 _gno. 7 _gp. 942-950
856	4	0	_uhttps://doi.org/10.1016/j.annonc.2020.04.001 _zAvailable from publisher's website
999			_c30861463 _d30861463